EAN Congress: Hearing Aids Linked to Lower Dementia Risk in Epileptic Patients
Research presented at the 2026 European Academy of Neurology (EAN) congress has revealed an intriguing connection between the use of hearing aids and a reduced risk of dementia in adults suffering from both epilepsy and hearing loss.
Importance of Research Findings
A study led by researchers from the University Hospital Zurich and the University of Liverpool investigated the correlation between hearing aid usage and dementia risk in adults. The large-scale analysis utilized electronic health records from over 250 million patients within the TriNetX network, which provided a comprehensive database for comparison.
The key finding indicates that adults who have both epilepsy and hearing loss and use hearing aids have a 23% lower risk of developing dementia compared to those who do not use these devices. This translates to an absolute risk reduction of 2.7 percentage points over a five-year period, suggesting that for every 37 individuals who wear hearing aids, there is one fewer case of dementia.
Understanding Hearing Loss and Dementia
Hearing loss has long been regarded as a significant modifiable risk factor for dementia. Despite this, the relationship between hearing aids and dementia risk has remained a topic of debate within the medical community. Researchers aimed to determine whether the use of hearing aids could mitigate this risk, particularly among those suffering from additional neurological conditions.
The overall analysis grouped individuals with hearing loss, including those with epilepsy, stroke, type 2 diabetes, chronic kidney disease, heart failure, migraines, and osteoarthritis. Surprisingly, there was no significant connection found between hearing aid use and dementia risk among the broader population with hearing loss or other neurological disorders.
Specific Findings for Epileptic Patients
In contrast, the results for adults with both epilepsy and hearing loss were striking. The authors suggest that cognitive reserve—the brain’s ability to function effectively despite aging or disease—may explain these findings. Dr. Carolina Ferreira-Atuesta, the lead author of the study, explained that most individuals with hearing loss have enough cognitive reserve to compensate for the additional challenges posed by their condition. However, those with epilepsy may have a compromised cognitive reserve, making them more susceptible to additional stressors such as hearing impairment.
Biological Mechanisms Behind the Findings
Several biological explanations may account for why hearing aids can influence dementia risk specifically in people with epilepsy. The condition is often associated with accelerated cognitive decline, and temporal lobe epilepsy affects areas of the brain crucial for auditory processing. Furthermore, certain antiepileptic medications may impair hearing, compounding the problem.
Implications for Clinical Practice
The implications of these findings are noteworthy for clinical practice. Given that individuals with epilepsy frequently engage with healthcare systems, routine hearing assessments could be seamlessly integrated into their care. This proactive approach might enhance the management of both hearing loss and associated dementia risk, potentially improving quality of life and cognitive health for these vulnerable populations.
Conclusion
While the link between hearing aids and reduced dementia risk among the general population remains inconclusive, the evidence for patients with concurrent epilepsy and hearing loss is compelling. This research highlights the necessity for further studies to explore the relationship between auditory health and cognitive decline, especially in those with neurological conditions. As we gain deeper insights into these associations, the potential benefits of early intervention through hearing aids are becoming increasingly clear, promising a better future for many at risk of dementia.
